查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1551287

2030 年組織工程市場預測：按產品類型、技術、應用、最終用戶和地區分類的全球分析

Tissue Engineering Market Forecasts to 2030 - Global Analysis By Product (Scaffolds, Cell Culture, Hydrogels, 3D Bioprinting and Other Products), Material Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球組織工程市場規模將達51億美元，預計2030年將達到134億美元，預測期內複合年成長率為17.3%。

組織工程是一個跨學科領域，結合生物學和工程學的原理，創造生物替代品，以恢復、維持和改善受損組織和器官的功能。這個過程通常使用細胞、支架和生化因子來開發用於醫療應用的可行組織結構。組織工程涵蓋多種技術和應用，包括皮膚、軟骨和器官修復，在再生醫學中發揮重要作用。

根據 2022 年 5 月發表的一項題為「脊髓損傷女性的性和浪漫經歷：印度背景的見解」的研究，估計全球每年約有 25 萬至 50 萬人經歷脊髓損傷 (SCI)。

對再生醫學的需求不斷成長

對再生醫學不斷成長的需求是市場的主要促進因素。慢性病、器官衰竭和組織損傷的日益普及正在推動對組織工程提供的再生療法的需求。組織工程旨在透過使用細胞和支架開發生物替代品來恢復、維持和改善組織功能。這個跨學科領域結合了生物學和工程學原理，為皮膚、軟骨和器官修復等醫學應用創建可行的組織結構。

製造擴充性

製造可擴展性給市場帶來了重大挑戰，並對市場成長潛力產生了負面影響。大規模製造組織工程產品的複雜性往往會導致品質和性能的變化，從而阻礙監管部門的核准和市場進入。因此，技術創新的步伐將會放緩，醫療保健市場中組織工程解決方案的整體可用性將會下降，進而影響患者的治療結果和治療選擇。

醫療保健支出增加

由於其具有減少手術侵入性和縮短恢復時間等優點，組織支架的使用也正在增加。這項投資是為了滿足對器官衰竭、退化性疾病和創傷等疾病的創新治療日益成長的需求。隨著醫療保健系統優先考慮具有成本效益的長期解決方案，該市場正在加速成長。總的來說，這些因素都有助於組織工程和再生解決方案市場的擴大。

治療費用高

所使用的先進技術，如生物材料、生長因子、活細胞、支架和功能基質，使得組織工程治療對患者來說昂貴。這限制了取得和採用，特別是在人口眾多但醫療預算有限的發展中地區。克服高治療成本帶來的經濟障礙對於市場充分發揮潛力並為更多患者群體帶來再生解決方案至關重要。

COVID-19 的影響：

COVID-19 透過加速再生療法的研究和加強對病毒引起的嚴重組織損傷的解決方案的開發來影響市場。此次疫情凸顯了對先進組織修復技術的需求，並刺激了對相關研究的投資。然而，它也造成了供應鏈和臨床試驗的中斷。總體而言，疫情加劇了組織工程創新的迫切性，同時為生產和開發時間表帶來了挑戰。

支架部分預計將成為預測期內最大的部分

預計支架在預測期內將達到最高水準。這些構建體可以由合成或生物衍生材料製成，旨在模擬自然組織的細胞外基質。支架透過促進細胞增殖和分化來促進骨骼、軟骨和皮膚等各種組織的再生。 3D 列印和水凝膠等技術創新正在增強支架設計，並為再生醫學中複雜的組織修復和再生需求提供更有效和客製化的解決方案。

預計脫細胞細分市場在預測期內複合年成長率最高。

預計去細胞化領域在預測期內將出現最高的複合年成長率。該技術創建了一個支持細胞附著和生長、促進組織再生的支架。當使用患者特異性細胞進行再細胞化時，去細胞支架有利於保留天然生化線索和機械特性並促進更大的完整性和功能。這種方法增加了成功組織修復的可能性，並已應用於多個領域，包括再生醫學和器官移植。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。由於主要企業的強大影響力和支持組織工程創新的有利政府政策，該地區佔據了主導市場佔有率。該地區先進的醫療基礎設施和高支出進一步鼓勵採用創新的組織工程解決方案，以滿足許多患有退化性疾病和損傷的患者的需求。

複合年成長率最高的地區：

由於醫療保健需求的成長、再生醫學的進步以及慢性病患病率的增加，預計亞太地區在預測期內將保持最高的複合年成長率。該地區的主要參與者正在投資新技術和方法，以增強組織再生並應對組織特異性材料開發等挑戰。不斷成長的老年人口和政府改善醫療基礎設施的努力進一步推動了這個充滿活力的地區的市場擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球組織工程市場：依產品

  • 鷹架
  • 細胞培養
  • 水凝膠
  • 3D生物列印
  • 其他產品

第6章全球組織工程市場：依材料類型

  • 合成材料
  • 生物材料
  • 複合材料
  • 生物陶瓷

第7章全球組織工程市場：依技術分類

  • 靜電紡絲
  • 冷凍保存
  • 去細胞化
  • 基因編輯
  • 再生醫學
  • 其他技術

第8章全球組織工程市場：依應用分類

  • 整形外科
  • 神經病學
  • 心血管
  • 皮膚和體被
  • 牙科
  • 其他用途

第9章全球組織工程市場：依最終使用者分類

  • 醫院/診所
  • 研究實驗室
  • 學術機構
  • 其他最終用戶

第10章全球組織工程市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • Athersys Inc.
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Vericel Corporation
  • Regenative Labs LLC
  • MiMedx Group Inc.
  • TissueTech Inc.
  • Stryker Corporation
  • Celgene Corporation
  • Medtronic plc
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • Corning Inc.
  • Glycosan BioSystems Inc.
  • Centrica Inc.
  • Arthrex Inc.
Product Code: SMRC27070

According to Stratistics MRC, the Global Tissue Engineering Market is accounted for $5.1 billion in 2024 and is expected to reach $13.4 billion by 2030 growing at a CAGR of 17.3% during the forecast period. Tissue engineering is a multidisciplinary field that combines principles from biology and engineering to create biological substitutes aimed at restoring, maintaining, or improving the function of damaged tissues or organs. This process often involves using cells, scaffolds, and biochemical factors to develop viable tissue constructs for medical applications. Tissue engineering encompasses a variety of techniques and applications, including the repair of skin, cartilage, and organs, and plays a crucial role in regenerative medicine

According to a research study titled "Sexuality and relationship experiences of women with spinal cord injury: reflections from an Indian context", published in May 2022, it is estimated that approximately 250,000-500,000 people worldwide experience a spinal cord injury (SCI) annually.

Market Dynamics:

Driver:

Growing need for regenerative medicines

The growing need for regenerative medicines is a key driver of the market. Increasing prevalence of chronic diseases, organ failures, and tissue damage is fueling demand for regenerative therapies that tissue engineering can provide. Tissue engineering aims to restore, maintain, or improve tissue function by developing biological substitutes using cells, scaffolds. This multidisciplinary field combines principles from biology and engineering to create viable tissue constructs for medical applications like skin, cartilage, and organ repair.

Restraint:

Manufacturing scalability

Manufacturing scalability poses significant challenges in the market, negatively affecting its growth potential. The complexity of producing tissue-engineered products at scale often leads to inconsistencies in quality and performance, which can hinder regulatory approval and market entry. This results in a slower pace of innovation and reduces the overall availability of tissue-engineered solutions in the healthcare market, impacting patient outcomes and treatment options.

Opportunity:

Rising healthcare expenditure

The adoption of tissue scaffolds is also on the rise due to their benefits like reduced surgical invasiveness and faster recovery times. This investment addresses the growing demand for innovative treatments for conditions like organ failure, degenerative diseases, and traumatic injuries. As healthcare systems prioritize cost-effective, long-term solutions, the market sees accelerated growth. These factors collectively contribute to the expanding market for tissue engineering and regeneration solutions.

Threat:

High treatment cost

The advanced technologies used, including biomaterials, growth factors, living cells, scaffolds, and functional matrices, make tissue engineering treatments expensive for patients. This limits accessibility and adoption, especially in developing regions with large populations but limited healthcare budgets. Overcoming the financial barriers posed by high treatment costs will be crucial for the market to reach its full potential and provide regenerative solutions to a wider patient population.

Covid-19 Impact:

COVID-19 has impacted the market by accelerating research into regenerative therapies and enhancing focus on developing solutions for severe tissue damage caused by the virus. The pandemic has highlighted the need for advanced tissue repair technologies and driven investments in related research. However, it also caused disruptions in supply chains and clinical trials. Overall, the pandemic has increased urgency for innovations in tissue engineering while presenting challenges in production and development timelines.

The scaffolds segment is expected to be the largest during the forecast period

The scaffolds is expected to be the largest during the forecast period. These structures can be made from synthetic or biologically derived materials, designed to mimic the extracellular matrix of natural tissues. Scaffolds facilitate the regeneration of various tissues, including bone, cartilage, and skin, by promoting cell proliferation and differentiation. Innovations such as 3D printing and hydrogels are enhancing scaffold design, enabling more effective and tailored solutions for complex tissue repair and regeneration needs in regenerative medicine.

The decellularized segment is expected to have the highest CAGR during the forecast period

The decellularized segment is expected to have the highest CAGR during the forecast period. This technique creates scaffolds that can support cell attachment and growth, facilitating tissue regeneration. Decellularized scaffolds are advantageous as they retain natural biochemical cues and mechanical properties, promoting better integration and functionality when recellularized with patient-specific cells. This approach enhances the potential for successful tissue repair and has applications in various fields, including regenerative medicine and organ transplantation.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region holds a dominant market share, driven by a robust presence of leading companies, and favorable government policies supporting innovation in tissue engineering. The region's advanced healthcare infrastructure and high spending further enhance the adoption of innovative tissue engineering solutions, addressing the needs of a large patient population suffering from degenerative conditions and injuries.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period driven by rising healthcare demands, advancements in regenerative medicine, and an increasing prevalence of chronic diseases. Key players in the region are investing in new technologies and methodologies to enhance tissue regeneration, addressing challenges such as the development of tissue-specific materials. The increasing geriatric population and government initiatives to improve healthcare infrastructure further support market expansion in this dynamic region.

Key players in the market

Some of the key players in Tissue Engineering market include Athersys Inc., Osiris Therapeutics Inc., Cytori Therapeutics Inc., Vericel Corporation, Regenative Labs LLC, MiMedx Group Inc., TissueTech Inc., Stryker Corporation, Celgene Corporation, Medtronic plc, Amgen Inc., Thermo Fisher Scientific Inc., Corning Inc., Glycosan BioSystems Inc., Centrica Inc. and Arthrex Inc.

Key Developments:

In April 2024, Medtronic plc announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra(TM) valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It's an excellent choice for cardiac surgeons and their patients seeking an aortic valve solution that can be fit for the future, right from the start.

In January 2024, Arthrex has launched a new patient-focused resource, TheNanoExperience.com, highlighting the science and benefits of Nano arthroscopy, a modern, least-invasive orthopedic procedure that may allow for a quick return to activity and less pain.

Products Covered:

  • Scaffolds
  • Cell Culture
  • Hydrogels
  • 3D Bioprinting
  • Other Products

Material Types Covered:

  • Synthetic Materials
  • Biological Materials
  • Composite Materials
  • Bioceramics

Technologies Covered:

  • Electrospinning
  • Cryopreservation
  • Decellularization
  • Gene Editing
  • Regenerative Medicine
  • Other Technologies

Applications Covered:

  • Orthopedics
  • Neurology
  • Cardiovascular
  • Skin & Integumentary
  • Dental
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Research Laboratories
  • Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tissue Engineering Market, By Product

  • 5.1 Introduction
  • 5.2 Scaffolds
  • 5.3 Cell Culture
  • 5.4 Hydrogels
  • 5.5 3D Bioprinting
  • 5.6 Other Products

6 Global Tissue Engineering Market, By Material Type

  • 6.1 Introduction
  • 6.2 Synthetic Materials
  • 6.3 Biological Materials
  • 6.4 Composite Materials
  • 6.5 Bioceramics

7 Global Tissue Engineering Market, By Technology

  • 7.1 Introduction
  • 7.2 Electrospinning
  • 7.3 Cryopreservation
  • 7.4 Decellularization
  • 7.5 Gene Editing
  • 7.6 Regenerative Medicine
  • 7.7 Other Technologies

8 Global Tissue Engineering Market, By Application

  • 8.1 Introduction
  • 8.2 Orthopedics
  • 8.3 Neurology
  • 8.4 Cardiovascular
  • 8.5 Skin & Integumentary
  • 8.6 Dental
  • 8.7 Other Applications

9 Global Tissue Engineering Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Research Laboratories
  • 9.4 Academic Institutes
  • 9.5 Other End Users

10 Global Tissue Engineering Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Athersys Inc.
  • 12.2 Osiris Therapeutics Inc.
  • 12.3 Cytori Therapeutics Inc.
  • 12.4 Vericel Corporation
  • 12.5 Regenative Labs LLC
  • 12.6 MiMedx Group Inc.
  • 12.7 TissueTech Inc.
  • 12.8 Stryker Corporation
  • 12.9 Celgene Corporation
  • 12.10 Medtronic plc
  • 12.11 Amgen Inc.
  • 12.12 Thermo Fisher Scientific Inc.
  • 12.13 Corning Inc.
  • 12.14 Glycosan BioSystems Inc.
  • 12.15 Centrica Inc.
  • 12.16 Arthrex Inc.

List of Tables

  • Table 1 Global Tissue Engineering Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Tissue Engineering Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Tissue Engineering Market Outlook, By Scaffolds (2022-2030) ($MN)
  • Table 4 Global Tissue Engineering Market Outlook, By Cell Culture (2022-2030) ($MN)
  • Table 5 Global Tissue Engineering Market Outlook, By Hydrogels (2022-2030) ($MN)
  • Table 6 Global Tissue Engineering Market Outlook, By 3D Bioprinting (2022-2030) ($MN)
  • Table 7 Global Tissue Engineering Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 8 Global Tissue Engineering Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 9 Global Tissue Engineering Market Outlook, By Synthetic Materials (2022-2030) ($MN)
  • Table 10 Global Tissue Engineering Market Outlook, By Biological Materials (2022-2030) ($MN)
  • Table 11 Global Tissue Engineering Market Outlook, By Composite Materials (2022-2030) ($MN)
  • Table 12 Global Tissue Engineering Market Outlook, By Bioceramics (2022-2030) ($MN)
  • Table 13 Global Tissue Engineering Market Outlook, By Technology (2022-2030) ($MN)
  • Table 14 Global Tissue Engineering Market Outlook, By Electrospinning (2022-2030) ($MN)
  • Table 15 Global Tissue Engineering Market Outlook, By Cryopreservation (2022-2030) ($MN)
  • Table 16 Global Tissue Engineering Market Outlook, By Decellularization (2022-2030) ($MN)
  • Table 17 Global Tissue Engineering Market Outlook, By Gene Editing (2022-2030) ($MN)
  • Table 18 Global Tissue Engineering Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 19 Global Tissue Engineering Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 20 Global Tissue Engineering Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Tissue Engineering Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 22 Global Tissue Engineering Market Outlook, By Neurology (2022-2030) ($MN)
  • Table 23 Global Tissue Engineering Market Outlook, By Cardiovascular (2022-2030) ($MN)
  • Table 24 Global Tissue Engineering Market Outlook, By Skin & Integumentary (2022-2030) ($MN)
  • Table 25 Global Tissue Engineering Market Outlook, By Dental (2022-2030) ($MN)
  • Table 26 Global Tissue Engineering Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Global Tissue Engineering Market Outlook, By End User (2022-2030) ($MN)
  • Table 28 Global Tissue Engineering Market Outlook, By Hospitals & Clinics (2022-2030) ($MN)
  • Table 29 Global Tissue Engineering Market Outlook, By Research Laboratories (2022-2030) ($MN)
  • Table 30 Global Tissue Engineering Market Outlook, By Academic Institutes (2022-2030) ($MN)
  • Table 31 Global Tissue Engineering Market Outlook, By Other End Users (2022-2030) ($MN) (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.